Sichuan Zitonggong Pharmaceutical Co (BJSE:832566) Total Liabilities : ¥127.6 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sichuan Zitonggong Pharmaceutical Co Total Liabilities?

Sichuan Zitonggong Pharmaceutical Co's Total Liabilities for the quarter that ended in Sep. 2024 was ¥127.6 Mil.

Sichuan Zitonggong Pharmaceutical Co's quarterly Total Liabilities declined from Mar. 2024 (¥142.92 Mil) to Jun. 2024 (¥132.79 Mil) and declined from Jun. 2024 (¥132.79 Mil) to Sep. 2024 (¥127.58 Mil).

Sichuan Zitonggong Pharmaceutical Co's annual Total Liabilities increased from Dec. 2021 (¥129.70 Mil) to Dec. 2022 (¥130.32 Mil) but then declined from Dec. 2022 (¥130.32 Mil) to Dec. 2023 (¥127.60 Mil).

Sichuan Zitonggong Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Sichuan Zitonggong Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Zitonggong Pharmaceutical Co Total Liabilities Chart

Sichuan Zitonggong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

158.97

112.61

129.70

130.32

127.60

Sichuan Zitonggong Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															133.95	127.60	142.92	132.79	127.58

Sichuan Zitonggong Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sichuan Zitonggong Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	76.499	+	(4.022	+	47.079
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	127.6

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	878.202	-	750.602
	=	127.6

Sichuan Zitonggong Pharmaceutical Co's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	68.555	+	(13.098	+	45.929
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	127.6

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	895.389	-	767.807
	=	127.6

Sichuan Zitonggong Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Sichuan Zitonggong Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sichuan Zitonggong Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sichuan Zitonggong Pharmaceutical Co Ltd (BJSE:832566) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No. 456, Anji Street, Economic and Technological Development Zone, Sichuan Province, Neijiang, CHN, 641000

Website

http://www.zitonggong.com

Sichuan Zitonggong Pharmaceutical Co Ltd is a high-tech enterprise focusing on the R&D, production, and marketing of tablets, hard capsules, liniments, powders, and ointments. It has developed a number of drug varieties such as Citicoline Sodium Tablets and Rizatriptan Benzoate Capsules.

Sichuan Zitonggong Pharmaceutical Co Headlines

No Headlines